AMATO, MARIA PIA
AMATO, MARIA PIA
Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino (NEUROFARBA)
"Brain reserve" and "cognitive reserve" should always be taken into account when studying neurodegeneration - Commentary
2018 Amato, MP;
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.
2009 O'Connor, P; Filippi, M; Arnason, B; Comi, G; Cook, S; Goodin, D; Hartung, Hp; Jeffery, D; Kappos, L; Boateng, F; Filippov, V; Groth, M; Knappertz, V; Kraus, C; Sandbrink, R; Pohl, C; Bogumil, T; Amato, Mp
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.
2015 Kuhle, J; Hardmeier, M; Baum, K; Amato, Mp; Buttmann, M
A case of Takotsubo syndrome during a multiple sclerosis brainstem relapse
2018 Prestipino, Elio; Squitieri, Martina; Razzolini, Lorenzo; Pastò, Luisa; Forleo, Paolo; Amato, Maria Pia
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients
2015 Niccolai, Claudia; Portaccio, Emilio; Goretti, Benedetta; Hakiki, Bahia; Giannini, Marta; Pastò, Luisa; Righini, Isabella; Falautano, Monica; Minacapelli, Eleonora; Martinelli, Vittorio; Incerti, Chiara; Nocentini, Ugo; Fenu, Giuseppe; Cocco, Eleonora; Marrosu, Maria Giovanna; Garofalo, Elisa; Ambra, Ferdinando Ivano; Maddestra, Maurizio; Consalvo, Marilena; Viterbo, Rosa Gemma; Trojano, Maria; Losignore, Nunzia Alessandra; Zimatore, Giovanni Bosco; Pietrolongo, Erika; Lugaresi, Alessandra; Pippolo, Lorena; Roscio, Marco; Ghezzi, Angelo; Castellano, Debora; Stecchi, Sergio; Amato, Maria Pia
A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN.
2004 F. Patti; M. P. Amato; M. Filippi; P. Gallo; M. Trojano; G. C. Comi
A first step towards preventive medicine in multiple sclerosis
2023 Amato, Maria Pia; Portaccio, Emilio
A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patients
2020 Mallucci G.; Patti F.; Brescia Morra V.; Buccafusca M.; Moiola L.; Amato M.P.; Ferraro E.; Trojano M.; Zaffaroni M.; Mirabella M.; Moscato G.; Plewnia K.; Zipoli V.; Puma E.; Bergamaschi R.
A new paraplegin mutation in a patient with primary progressive multiple sclerosis
2020 Bellinvia A.; Pasto L.; Niccolai C.; Tessa A.; Carrai R.; Martinelli C.; Moretti M.; Amato M.P.; Santorelli F.M.; Sorbi S.; Mata S.
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
2010 Giovannoni G; Comi G; Cook S; Rammohan K; Rieckmann P; Soelberg Sørensen P; Vermersch P; Chang P; Hamlett A; Musch B; Greenberg SJ; MP. Amato; CLARITY Study Group.
A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials.
1999 M. P. Amato; G. Ponziani; M. L. Bartolozzi; G. Siracusa
A prospective study on the prognosis of multiple sclerosis.
2000 M. P. Amato; G. Ponziani
A prospective, randomized, controlled trial of autologus haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.
2012 Saccardi R, Freedman MS; Sormani, Mp; Atkins, H; Fsrge, D; Griffith, Lm; Kraft, G; Gl, Mancardi; Nash, R; Pasquini, M; Martin, R; Amato, Mp
A quality network model for the daily care of multiple sclerosis.
2000 L. D. Blumhardt; B. J. D. Vermeij; M. P. Amato; O. Andersen; G. Edan; O. Fernandez; M. Filippi; J. Haas; O. R. Hommes; P. Rieckmann
A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis.
2009 Portaccio, E;Goretti, B;Zipoli, V;Siracusa, G;Sorbi, S;Amato, MP
A steroid-induced bilateral avascular necrosis of the femoral head in an underage patient affected by multiple sclerosis
2015 Carulli, Christian; Nistri, Lorenzo; Bracco, Laura; Giannini, Marta; Amato, Maria Pia
Abnormal cerebellar functional MRI connectivity in patients with paediatric multiple sclerosis.
2015 Cirillo, S; Rocca, Ma; Ghezzi, A; Valsasina, P; Moiola, L; Veggiotti, P; Amato, Mp; Comi, G; Falini, A; Filippi, M.
Abnormal thalamic functional connectivity correlates with cardiorespiratory fitness and physical activity in progressive multiple sclerosis
2023 Romanò, Francesco; Motl, Robert W; Valsasina, Paola; Amato, Maria Pia; Brichetto, Giampaolo; Bruschi, Nicolò; Chataway, Jeremy; Chiaravalloti, Nancy D; Cutter, Gary; Dalgas, Ulrik; DeLuca, John; Farrell, Rachel; Feys, Peter; Freeman, Jennifer; Inglese, Matilde; Meza, Cecilia; Salter, Amber; Sandroff, Brian M; Feinstein, Anthony; Rocca, Maria A; Filippi, Massimo
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta
2006 ANNUNZIATA P; GIORGIO A; DE SANTI L; ZIPOLI V; PORTACCIO E; M.P. AMATO; CLERICI R; SCARPINI E; MOSCATO G; IUDICE A; VACCA G; OREFICE G; MORRA VB; MAIMONE D
Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis.
1993 A. Solari; M. P. Amato; R. Bergamaschi; G. Logroscino; A. Citterio; D. Bochicchio; G. Filippini
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Brain reserve" and "cognitive reserve" should always be taken into account when studying neurodegeneration - Commentary | 2018 | Amato, MP; | |
| 250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. | 2009 | O'Connor, P; Filippi, M; Arnason, B; Comi, G; Cook, S; Goodin, D; Hartung, Hp; Jeffery, D; Kappos, L; Boateng, F; Filippov, V; Groth, M; Knappertz, V; Kraus, C; Sandbrink, R; Pohl, C; Bogumil, T; Amato, Mp | |
| A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis. | 2015 | Kuhle, J; Hardmeier, M; Baum, K; Amato, Mp; Buttmann, M | |
| A case of Takotsubo syndrome during a multiple sclerosis brainstem relapse | 2018 | Prestipino, Elio; Squitieri, Martina; Razzolini, Lorenzo; Pastò, Luisa; Forleo, Paolo; Amato, Maria Pia | |
| A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients | 2015 | Niccolai, Claudia; Portaccio, Emilio; Goretti, Benedetta; Hakiki, Bahia; Giannini, Marta; Pastò, Luisa; Righini, Isabella; Falautano, Monica; Minacapelli, Eleonora; Martinelli, Vittorio; Incerti, Chiara; Nocentini, Ugo; Fenu, Giuseppe; Cocco, Eleonora; Marrosu, Maria Giovanna; Garofalo, Elisa; Ambra, Ferdinando Ivano; Maddestra, Maurizio; Consalvo, Marilena; Viterbo, Rosa Gemma; Trojano, Maria; Losignore, Nunzia Alessandra; Zimatore, Giovanni Bosco; Pietrolongo, Erika; Lugaresi, Alessandra; Pippolo, Lorena; Roscio, Marco; Ghezzi, Angelo; Castellano, Debora; Stecchi, Sergio; Amato, Maria Pia | |
| A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN. | 2004 | F. Patti; M. P. Amato; M. Filippi; P. Gallo; M. Trojano; G. C. Comi | |
| A first step towards preventive medicine in multiple sclerosis | 2023 | Amato, Maria Pia; Portaccio, Emilio | |
| A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patients | 2020 | Mallucci G.; Patti F.; Brescia Morra V.; Buccafusca M.; Moiola L.; Amato M.P.; Ferraro E.; Trojano M.; Zaffaroni M.; Mirabella M.; Moscato G.; Plewnia K.; Zipoli V.; Puma E.; Bergamaschi R. | |
| A new paraplegin mutation in a patient with primary progressive multiple sclerosis | 2020 | Bellinvia A.; Pasto L.; Niccolai C.; Tessa A.; Carrai R.; Martinelli C.; Moretti M.; Amato M.P.; Santorelli F.M.; Sorbi S.; Mata S. | |
| A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. | 2010 | Giovannoni G; Comi G; Cook S; Rammohan K; Rieckmann P; Soelberg Sørensen P; Vermersch P; Chang P; Hamlett A; Musch B; Greenberg SJ; MP. Amato; CLARITY Study Group. | |
| A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials. | 1999 | M. P. Amato; G. Ponziani; M. L. Bartolozzi; G. Siracusa | |
| A prospective study on the prognosis of multiple sclerosis. | 2000 | M. P. Amato; G. Ponziani | |
| A prospective, randomized, controlled trial of autologus haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. | 2012 | Saccardi R, Freedman MS; Sormani, Mp; Atkins, H; Fsrge, D; Griffith, Lm; Kraft, G; Gl, Mancardi; Nash, R; Pasquini, M; Martin, R; Amato, Mp | |
| A quality network model for the daily care of multiple sclerosis. | 2000 | L. D. Blumhardt; B. J. D. Vermeij; M. P. Amato; O. Andersen; G. Edan; O. Fernandez; M. Filippi; J. Haas; O. R. Hommes; P. Rieckmann | |
| A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. | 2009 | Portaccio, E;Goretti, B;Zipoli, V;Siracusa, G;Sorbi, S;Amato, MP | |
| A steroid-induced bilateral avascular necrosis of the femoral head in an underage patient affected by multiple sclerosis | 2015 | Carulli, Christian; Nistri, Lorenzo; Bracco, Laura; Giannini, Marta; Amato, Maria Pia | |
| Abnormal cerebellar functional MRI connectivity in patients with paediatric multiple sclerosis. | 2015 | Cirillo, S; Rocca, Ma; Ghezzi, A; Valsasina, P; Moiola, L; Veggiotti, P; Amato, Mp; Comi, G; Falini, A; Filippi, M. | |
| Abnormal thalamic functional connectivity correlates with cardiorespiratory fitness and physical activity in progressive multiple sclerosis | 2023 | Romanò, Francesco; Motl, Robert W; Valsasina, Paola; Amato, Maria Pia; Brichetto, Giampaolo; Bruschi, Nicolò; Chataway, Jeremy; Chiaravalloti, Nancy D; Cutter, Gary; Dalgas, Ulrik; DeLuca, John; Farrell, Rachel; Feys, Peter; Freeman, Jennifer; Inglese, Matilde; Meza, Cecilia; Salter, Amber; Sandroff, Brian M; Feinstein, Anthony; Rocca, Maria A; Filippi, Massimo | |
| Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta | 2006 | ANNUNZIATA P; GIORGIO A; DE SANTI L; ZIPOLI V; PORTACCIO E; M.P. AMATO; CLERICI R; SCARPINI E; MOSCATO G; IUDICE A; VACCA G; OREFICE G; MORRA VB; MAIMONE D | |
| Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis. | 1993 | A. Solari; M. P. Amato; R. Bergamaschi; G. Logroscino; A. Citterio; D. Bochicchio; G. Filippini |